| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | regulation of canonical Wnt signaling pathway | 3.42e-05 | 285 | 45 | 6 | GO:0060828 | |
| GeneOntologyBiologicalProcess | lens development in camera-type eye | 7.47e-05 | 103 | 45 | 4 | GO:0002088 | |
| GeneOntologyBiologicalProcess | canonical Wnt signaling pathway | 9.70e-05 | 344 | 45 | 6 | GO:0060070 | |
| GeneOntologyBiologicalProcess | lens fiber cell differentiation | 1.21e-04 | 44 | 45 | 3 | GO:0070306 | |
| GeneOntologyBiologicalProcess | positive regulation of canonical Wnt signaling pathway | 1.39e-04 | 121 | 45 | 4 | GO:0090263 | |
| GeneOntologyBiologicalProcess | regulation of Wnt signaling pathway | 1.40e-04 | 368 | 45 | 6 | GO:0030111 | |
| GeneOntologyBiologicalProcess | mitochondrion organization | 2.64e-04 | 589 | 45 | 7 | GO:0007005 | |
| GeneOntologyBiologicalProcess | epithelial cell development | 2.90e-04 | 269 | 45 | 5 | GO:0002064 | |
| GeneOntologyBiologicalProcess | positive regulation of Wnt signaling pathway | 3.87e-04 | 158 | 45 | 4 | GO:0030177 | |
| GeneOntologyBiologicalProcess | mitochondrial respiratory chain complex I assembly | 4.03e-04 | 66 | 45 | 3 | GO:0032981 | |
| GeneOntologyBiologicalProcess | NADH dehydrogenase complex assembly | 4.03e-04 | 66 | 45 | 3 | GO:0010257 | |
| GeneOntologyCellularComponent | platelet dense tubular network membrane | 1.84e-04 | 9 | 48 | 2 | GO:0031095 | |
| GeneOntologyCellularComponent | cell cortex | 1.96e-04 | 371 | 48 | 6 | GO:0005938 | |
| GeneOntologyCellularComponent | platelet dense tubular network | 2.80e-04 | 11 | 48 | 2 | GO:0031094 | |
| GeneOntologyCellularComponent | hippocampal mossy fiber to CA3 synapse | 4.91e-04 | 67 | 48 | 3 | GO:0098686 | |
| GeneOntologyCellularComponent | asymmetric synapse | 7.45e-04 | 477 | 48 | 6 | GO:0032279 | |
| Domain | NDUF_C2 | 6.20e-06 | 2 | 47 | 2 | PF06374 | |
| Domain | NADH-UbQ_OxRdtase_b14.5b_su | 6.20e-06 | 2 | 47 | 2 | IPR009423 | |
| Domain | CK1gamma_C | 1.86e-05 | 3 | 47 | 2 | PF12605 | |
| Domain | Casein_kinase-1_gamma_C | 1.86e-05 | 3 | 47 | 2 | IPR022247 | |
| Domain | HMG_boxA_CS | 1.86e-05 | 3 | 47 | 2 | IPR017967 | |
| Domain | HMG_box_2 | 2.21e-04 | 9 | 47 | 2 | PF09011 | |
| Domain | HMG_BOX_1 | 2.75e-04 | 10 | 47 | 2 | PS00353 | |
| Domain | Dynein_heavy_chain_D4_dom | 5.53e-04 | 14 | 47 | 2 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 5.53e-04 | 14 | 47 | 2 | IPR013602 | |
| Domain | DHC_N2 | 5.53e-04 | 14 | 47 | 2 | PF08393 | |
| Domain | AAA_8 | 5.53e-04 | 14 | 47 | 2 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 5.53e-04 | 14 | 47 | 2 | IPR011704 | |
| Domain | AAA_5 | 5.53e-04 | 14 | 47 | 2 | PF07728 | |
| Domain | HMG_box_dom | 5.85e-04 | 65 | 47 | 3 | IPR009071 | |
| Domain | DHC_fam | 6.37e-04 | 15 | 47 | 2 | IPR026983 | |
| Domain | CRYSTALLIN_BETA_GAMMA | 6.37e-04 | 15 | 47 | 2 | PS50915 | |
| Domain | Dynein_heavy_dom | 6.37e-04 | 15 | 47 | 2 | IPR004273 | |
| Domain | Crystall | 6.37e-04 | 15 | 47 | 2 | PF00030 | |
| Domain | Beta/gamma_crystallin | 6.37e-04 | 15 | 47 | 2 | IPR001064 | |
| Domain | Dynein_heavy | 6.37e-04 | 15 | 47 | 2 | PF03028 | |
| Domain | XTALbg | 6.37e-04 | 15 | 47 | 2 | SM00247 | |
| Domain | G_crystallin-rel | 9.24e-04 | 18 | 47 | 2 | IPR011024 | |
| Domain | - | 2.46e-03 | 746 | 47 | 7 | 3.40.50.300 | |
| Domain | P-loop_NTPase | 5.00e-03 | 848 | 47 | 7 | IPR027417 | |
| Domain | PDZ | 5.36e-03 | 141 | 47 | 3 | PF00595 | |
| Domain | AAA+_ATPase | 5.68e-03 | 144 | 47 | 3 | IPR003593 | |
| Domain | AAA | 5.68e-03 | 144 | 47 | 3 | SM00382 | |
| Domain | PDZ | 6.13e-03 | 148 | 47 | 3 | SM00228 | |
| Domain | - | 6.36e-03 | 150 | 47 | 3 | 2.30.42.10 | |
| Domain | PDZ | 6.48e-03 | 151 | 47 | 3 | PS50106 | |
| Domain | PDZ | 6.59e-03 | 152 | 47 | 3 | IPR001478 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 17509776 | ||
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 23761676 | ||
| Pubmed | Gamma-D crystallin gene (CRYGD) mutation causes autosomal dominant congenital cerulean cataracts. | 1.87e-06 | 2 | 48 | 2 | 12676897 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 37506315 | ||
| Pubmed | 3.22e-06 | 295 | 48 | 6 | 26209609 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 8666668 | ||
| Pubmed | Gamma-crystallin family of the mouse lens: structural and evolutionary relationships. | 5.59e-06 | 3 | 48 | 2 | 6096855 | |
| Pubmed | The gamma-crystallins and human cataracts: a puzzle made clearer. | 5.59e-06 | 3 | 48 | 2 | 10521291 | |
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 31621076 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 21732359 | ||
| Pubmed | Three murine cataract mutants (Cat2) are defective in different gamma-crystallin genes. | 5.59e-06 | 3 | 48 | 2 | 9782080 | |
| Pubmed | Multiple gamma-crystallins of the mouse lens: fractionation of mRNAs by cDNA cloning. | 5.59e-06 | 3 | 48 | 2 | 6953430 | |
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 12876325 | ||
| Pubmed | 1.11e-05 | 786 | 48 | 8 | 29128334 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 3428594 | ||
| Pubmed | Novel mutations in the gamma-crystallin genes cause autosomal dominant congenital cataracts. | 1.12e-05 | 4 | 48 | 2 | 12011157 | |
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 12507494 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 15037589 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 3011643 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 38385898 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 8626090 | ||
| Pubmed | Temporal regulation of six crystallin transcripts during mouse lens development. | 1.12e-05 | 4 | 48 | 2 | 1623964 | |
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 20621668 | ||
| Pubmed | Differential regulation of gamma-crystallin genes during mouse lens development. | 1.12e-05 | 4 | 48 | 2 | 3792630 | |
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 1511869 | ||
| Pubmed | Nectins establish a checkerboard-like cellular pattern in the auditory epithelium. | 1.86e-05 | 5 | 48 | 2 | 21798896 | |
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 19332538 | ||
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 21680713 | ||
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 10627816 | ||
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 9426193 | ||
| Pubmed | HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. | 1.86e-05 | 5 | 48 | 2 | 19890330 | |
| Pubmed | TMOD1 NDUFC2-KCTD14 EXOC1 CTNND1 SHANK2 MYO1E TJP1 ATAD3A NDUFC2 ITPR2 | 2.11e-05 | 1431 | 48 | 10 | 37142655 | |
| Pubmed | Gamma-crystallins of the human eye lens: expression analysis of five members of the gene family. | 2.79e-05 | 6 | 48 | 2 | 3670288 | |
| Pubmed | The cell adhesion gene PVRL3 is associated with congenital ocular defects. | 2.79e-05 | 6 | 48 | 2 | 21769484 | |
| Pubmed | 2.79e-05 | 6 | 48 | 2 | 23990464 | ||
| Pubmed | Human gamma-crystallin genes. A gene family on its way to extinction. | 2.79e-05 | 6 | 48 | 2 | 2258929 | |
| Pubmed | Expression patterns of nectins and afadin during epithelial remodeling in the mouse embryo. | 2.79e-05 | 6 | 48 | 2 | 15108322 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 4.44e-05 | 954 | 48 | 8 | 36373674 | |
| Pubmed | 5.16e-05 | 147 | 48 | 4 | 29576527 | ||
| Pubmed | Patched Receptors Sense, Interpret, and Establish an Epidermal Hedgehog Signaling Gradient. | 5.19e-05 | 8 | 48 | 2 | 27498049 | |
| Pubmed | 5.19e-05 | 8 | 48 | 2 | 9425147 | ||
| Pubmed | 5.19e-05 | 8 | 48 | 2 | 17130295 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 5.19e-05 | 8 | 48 | 2 | 19033399 | |
| Pubmed | 5.19e-05 | 8 | 48 | 2 | 22512338 | ||
| Pubmed | 6.67e-05 | 9 | 48 | 2 | 12515806 | ||
| Pubmed | 6.67e-05 | 9 | 48 | 2 | 32320651 | ||
| Pubmed | 6.67e-05 | 9 | 48 | 2 | 19170756 | ||
| Pubmed | 6.85e-05 | 57 | 48 | 3 | 38223760 | ||
| Pubmed | 7.64e-05 | 1335 | 48 | 9 | 29229926 | ||
| Pubmed | Contacts between the commissural axons and the floor plate cells are mediated by nectins. | 8.33e-05 | 10 | 48 | 2 | 15328010 | |
| Pubmed | Roles of cell-adhesion molecules nectin 1 and nectin 3 in ciliary body development. | 8.33e-05 | 10 | 48 | 2 | 15728677 | |
| Pubmed | Sox1 directly regulates the gamma-crystallin genes and is essential for lens development in mice. | 8.33e-05 | 10 | 48 | 2 | 9512512 | |
| Pubmed | 8.33e-05 | 10 | 48 | 2 | 25500533 | ||
| Pubmed | Regulation of lens fiber cell differentiation by transcription factor c-Maf. | 8.33e-05 | 10 | 48 | 2 | 10383433 | |
| Pubmed | 8.33e-05 | 10 | 48 | 2 | 22538088 | ||
| Pubmed | 8.86e-05 | 169 | 48 | 4 | 23665500 | ||
| Pubmed | 9.24e-05 | 63 | 48 | 3 | 20301682 | ||
| Pubmed | Shotgun identification of protein modifications from protein complexes and lens tissue. | 1.02e-04 | 11 | 48 | 2 | 12060738 | |
| Pubmed | 1.02e-04 | 11 | 48 | 2 | 10595510 | ||
| Pubmed | Mutations in C1orf194, encoding a calcium regulator, cause dominant Charcot-Marie-Tooth disease. | 1.02e-04 | 11 | 48 | 2 | 31199454 | |
| Pubmed | 1.02e-04 | 11 | 48 | 2 | 12446761 | ||
| Pubmed | 1.02e-04 | 11 | 48 | 2 | 33753518 | ||
| Pubmed | 1.02e-04 | 11 | 48 | 2 | 11146559 | ||
| Pubmed | 1.02e-04 | 11 | 48 | 2 | 21038445 | ||
| Pubmed | 1.02e-04 | 11 | 48 | 2 | 22479204 | ||
| Pubmed | 1.02e-04 | 11 | 48 | 2 | 24348274 | ||
| Pubmed | Altered aggregation properties of mutant gamma-crystallins cause inherited cataract. | 1.22e-04 | 12 | 48 | 2 | 12426373 | |
| Pubmed | 1.22e-04 | 12 | 48 | 2 | 26929452 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | 1.28e-04 | 569 | 48 | 6 | 30639242 | |
| Pubmed | 1.36e-04 | 1440 | 48 | 9 | 30833792 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | NDUFC2-KCTD14 CHD4 SCFD1 POGLUT2 NME3 TJP1 ATAD3A NDUFC2 TMEM181 | 1.44e-04 | 1451 | 48 | 9 | 30550785 |
| Pubmed | WDR1-regulated actin dynamics is required for outflow tract and right ventricle development. | 1.44e-04 | 13 | 48 | 2 | 29654745 | |
| Pubmed | 1.44e-04 | 13 | 48 | 2 | 28482867 | ||
| Pubmed | 1.60e-04 | 197 | 48 | 4 | 36604605 | ||
| Pubmed | The orchestration of mammalian tissue morphogenesis through a series of coherent feed-forward loops. | 1.68e-04 | 14 | 48 | 2 | 21998302 | |
| Pubmed | 1.68e-04 | 14 | 48 | 2 | 24381198 | ||
| Pubmed | Patched1 is required in neural crest cells for the prevention of orofacial clefts. | 1.68e-04 | 14 | 48 | 2 | 23900075 | |
| Pubmed | The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence. | 1.68e-04 | 14 | 48 | 2 | 22144466 | |
| Pubmed | 1.68e-04 | 14 | 48 | 2 | 9373155 | ||
| Pubmed | 1.68e-04 | 14 | 48 | 2 | 23789091 | ||
| Pubmed | 1.81e-04 | 382 | 48 | 5 | 29222160 | ||
| Pubmed | Human chromosome 11 DNA sequence and analysis including novel gene identification. | 1.88e-04 | 80 | 48 | 3 | 16554811 | |
| Pubmed | 1.94e-04 | 15 | 48 | 2 | 18393386 | ||
| Pubmed | 1.94e-04 | 15 | 48 | 2 | 10080188 | ||
| Pubmed | Association of CPI-17 with protein kinase C and casein kinase I. | 1.94e-04 | 15 | 48 | 2 | 15003508 | |
| Pubmed | FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells. | 2.12e-04 | 212 | 48 | 4 | 33462405 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | 2.14e-04 | 626 | 48 | 6 | 33644029 | |
| Pubmed | 2.21e-04 | 16 | 48 | 2 | 26116663 | ||
| Pubmed | 2.21e-04 | 16 | 48 | 2 | 15593327 | ||
| Pubmed | Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. | 2.33e-04 | 86 | 48 | 3 | 10862698 | |
| Pubmed | HSF4 is required for normal cell growth and differentiation during mouse lens development. | 2.50e-04 | 17 | 48 | 2 | 15483628 | |
| Pubmed | Identification of casein kinase Ialpha interacting protein partners. | 2.50e-04 | 17 | 48 | 2 | 12062430 | |
| Pubmed | 2.50e-04 | 17 | 48 | 2 | 22357932 | ||
| Pubmed | Differentially expressed genes in the lens of mimecan-null mice. | 2.50e-04 | 17 | 48 | 2 | 15215744 | |
| Pubmed | 2.52e-04 | 222 | 48 | 4 | 35941108 | ||
| Pubmed | Regulation of ocular lens development by Smad-interacting protein 1 involving Foxe3 activation. | 2.81e-04 | 18 | 48 | 2 | 16162653 | |
| Pubmed | 2.85e-04 | 660 | 48 | 6 | 32780723 | ||
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | 2.96e-04 | 665 | 48 | 6 | 30457570 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 2.97e-04 | 1257 | 48 | 8 | 36526897 | |
| Pubmed | p120 catenin is required for normal renal tubulogenesis and glomerulogenesis. | 3.14e-04 | 19 | 48 | 2 | 21521738 | |
| Interaction | COA1 interactions | 9.70e-07 | 32 | 48 | 4 | int:COA1 | |
| Cytoband | 11q14.1 | 8.97e-04 | 42 | 48 | 2 | 11q14.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p13 | 2.13e-03 | 65 | 48 | 2 | chr11p13 | |
| GeneFamily | Canonical high mobility group | 1.76e-04 | 11 | 33 | 2 | 511 | |
| GeneFamily | Beta-gamma crystallins | 3.34e-04 | 15 | 33 | 2 | 1359 | |
| GeneFamily | PDZ domain containing | 2.64e-03 | 152 | 33 | 3 | 1220 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.52e-08 | 200 | 48 | 6 | b9cede2e0939c6b60ce1aa16d7efaaae79354580 | |
| ToppCell | BAL-Severe-Epithelial|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.52e-08 | 200 | 48 | 6 | b762bf6f432eac05a476f6e2ab4da27dd13a2317 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.52e-08 | 200 | 48 | 6 | 4c63204e0d868dd4c11c1604a238624a3ad54485 | |
| ToppCell | Severe_COVID-19-Epithelial|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 7.52e-08 | 200 | 48 | 6 | 49910efb6d888c208cd50530b03af19f87070630 | |
| ToppCell | BAL-Severe-Epithelial|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.52e-08 | 200 | 48 | 6 | 0cc7ff7b6a4eb05d2370ec2f3b9dbfe8cb0699de | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 2.19e-06 | 196 | 48 | 5 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | Severe_COVID-19-Epithelial-transitional_Epi|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.25e-06 | 197 | 48 | 5 | 5ad3cd4c77016e862041baac3076f8cc0f75c417 | |
| ToppCell | BL-critical-LOC-Epithelial|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.30e-06 | 198 | 48 | 5 | 6218a25b94d5fa2c69880539adf9c63bfe52dcd3 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.42e-06 | 200 | 48 | 5 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.42e-06 | 200 | 48 | 5 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 2.11e-05 | 151 | 48 | 4 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.65e-05 | 160 | 48 | 4 | af84da18c85037f49f55e8958f00f12140226982 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.65e-05 | 160 | 48 | 4 | f7ca98beaa24f9674d503588eb15d341c4135d77 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.65e-05 | 160 | 48 | 4 | a76ad44b5f25f59d6b9333fb45f8bb96196a3090 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.94e-05 | 177 | 48 | 4 | f902600c639087664316b3cf30cab243bc3d1c5c | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.02e-05 | 178 | 48 | 4 | fba2e38c05cbf031e0c6d47b1602575fea734a57 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.11e-05 | 179 | 48 | 4 | 7394e77e665bf16d3733df91bb12907be460ab44 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell-TA|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.20e-05 | 180 | 48 | 4 | 271ee52ed8f21f78ddf68e52fc88fe582701675e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.29e-05 | 181 | 48 | 4 | 5bf7aa43f6e6ecce15c95928b91195544d6928c4 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.29e-05 | 181 | 48 | 4 | 8e751f5d7cd2d328ec0196d874e8a507e8c4e1a9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.67e-05 | 185 | 48 | 4 | 9197f074e769d54031ec41abfc65fcc0c6552c7e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.67e-05 | 185 | 48 | 4 | ce7d62394b09c26ca65b8cdb280afec5e25bbb62 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_basal|COVID-19 / group, cell type (main and fine annotations) | 4.87e-05 | 187 | 48 | 4 | 8407a82e98f56a94ea26562bcb6bbe00a8f41661 | |
| ToppCell | droplet-Marrow-nan-24m-Hematologic-erythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.08e-05 | 189 | 48 | 4 | 98ace332c3c046694c6ade47de8c8bf57ec51271 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-05 | 190 | 48 | 4 | 36e83995021ba16690f84e2077a9e8baec547d05 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-05 | 190 | 48 | 4 | c0ee404d705b0b4f0c6ded4d070ad85eac4b16db | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-05 | 190 | 48 | 4 | d26be9e1b676f750e716b91ebc3598fac3735612 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-05 | 191 | 48 | 4 | f76f3f5c7902a3659d8cbe470f96ce57c8a6744d | |
| ToppCell | COPD-Epithelial|COPD / Disease state, Lineage and Cell class | 5.40e-05 | 192 | 48 | 4 | 0644fad5df18f0021f6f49cca996d8cf47f972ff | |
| ToppCell | Control-Epithelial-Club|Control / Disease state, Lineage and Cell class | 5.40e-05 | 192 | 48 | 4 | d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16 | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 5.40e-05 | 192 | 48 | 4 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | ASK440-Epithelial-Secretory|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.51e-05 | 193 | 48 | 4 | 50e98d91697c7af6a3de39e52edde6dd2b67b512 | |
| ToppCell | Control-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 5.62e-05 | 194 | 48 | 4 | 958e648138676d46698090b4046cb484083ae449 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 5.73e-05 | 195 | 48 | 4 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 5.73e-05 | 195 | 48 | 4 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 5.73e-05 | 195 | 48 | 4 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.85e-05 | 196 | 48 | 4 | 9790340c25f446ec655f5a0b64ec3bb44ed2e1bd | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.85e-05 | 196 | 48 | 4 | b9ceceeacbcf81976ce92adf044f0d0aa132632b | |
| ToppCell | mLN-T_cell-gd_T|T_cell / Region, Cell class and subclass | 5.85e-05 | 196 | 48 | 4 | 8f476408cd5a4ea9d25c763c66565343d7989b38 | |
| ToppCell | COVID-19-Epithelial|COVID-19 / Condition, Lineage and Cell class | 5.97e-05 | 197 | 48 | 4 | 18fd7344628a87d5c7ef5efb66e260a4136245bf | |
| ToppCell | Bronchial_Brush-Epithelial|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.97e-05 | 197 | 48 | 4 | 272c7f4e582ef57564450540242b0db766b78328 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 6.08e-05 | 198 | 48 | 4 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.08e-05 | 198 | 48 | 4 | 10a091f7c713123865f316442f10a63493126a1c | |
| ToppCell | NS-critical-d_07-13|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.08e-05 | 198 | 48 | 4 | a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d | |
| ToppCell | PSB-critical-LOC-Epithelial|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.20e-05 | 199 | 48 | 4 | 58dcb0eedafa8629585dc99e53147e2287f49689 | |
| ToppCell | NS-critical-d_16-33-Epithelial|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.20e-05 | 199 | 48 | 4 | 3b68197ec01c5f2b315d9e9b6eb02d5f6b5b77a3 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.20e-05 | 199 | 48 | 4 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.20e-05 | 199 | 48 | 4 | 92fdf6e2f0786ab2ab78126e9131a93794168139 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.33e-05 | 200 | 48 | 4 | e1da1b15d2ca06796ee1ab7cef586ae0b4dc0a0a | |
| ToppCell | Bronchial-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.33e-05 | 200 | 48 | 4 | d3ee5f79513e2ac02ad3329b59e6290d457c44d2 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 6.33e-05 | 200 | 48 | 4 | d5426cd318a8f90c0bd8f9804351ab230fafc995 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.33e-05 | 200 | 48 | 4 | 21d9cf3cd3696ad6b745c7c036798f04b6ce5160 | |
| ToppCell | Biopsy_IPF-Epithelial|Biopsy_IPF / Sample group, Lineage and Cell type | 6.33e-05 | 200 | 48 | 4 | 76f1ac00b34d07057d8da03d276438b719b46b1d | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 6.33e-05 | 200 | 48 | 4 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.33e-05 | 200 | 48 | 4 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 6.33e-05 | 200 | 48 | 4 | f5bc7d30aa03dd0f95eb64255bd1a2543be8d327 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.33e-05 | 200 | 48 | 4 | 33658d5d09e2eaff60f4dd88837d4252328eab63 | |
| ToppCell | metastatic_Lymph_Node-Epithelial_cells|metastatic_Lymph_Node / Location, Cell class and cell subclass | 6.33e-05 | 200 | 48 | 4 | 07408011b37d32a20164866cf5da9dd120985357 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.41e-04 | 138 | 48 | 3 | f33cc2a5033aed5d02d175db5e521046a8e11b6c | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.63e-04 | 150 | 48 | 3 | c843bcf98c5fad2ca4339602f721f3fb782ae353 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.63e-04 | 150 | 48 | 3 | d6b977dd47aa017f6ba762f0c505cd896caa523f | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.63e-04 | 150 | 48 | 3 | 53de595376a9fc92491dfd58ff25938b0bf79903 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.63e-04 | 150 | 48 | 3 | e4b40b3243ed26d0c46bf196ac06e148834e7ed2 | |
| ToppCell | Basal_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 5.85e-04 | 152 | 48 | 3 | 72499e4d2b374ef5f1621c89d94727ecf4bd4d5d | |
| ToppCell | Control-PLT_4|World / Disease Group and Platelet Clusters | 6.08e-04 | 154 | 48 | 3 | a2a03c5e6759c45aeeedf1e68ecb5a0112ef9a20 | |
| ToppCell | BAL-Control-cDC_12|Control / Compartment, Disease Groups and Clusters | 6.08e-04 | 154 | 48 | 3 | 0121d08cc527aed9b3e11ff62bb9012916f5c56b | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.43e-04 | 157 | 48 | 3 | 6ee2692f705bdd93ba523dffaf2f0cd921b47e28 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.67e-04 | 159 | 48 | 3 | 5543f5aec6352a7c5923e55daf3ed40ff5cc0f0c | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-Tuft-related-Tuft|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.91e-04 | 161 | 48 | 3 | f5df8c6a340d5026726804b103e32137f363ca40 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.04e-04 | 162 | 48 | 3 | ca30d9bf61f4133566fdc91c7996e130ea554d01 | |
| ToppCell | Ciliated_cells-A-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 7.16e-04 | 163 | 48 | 3 | 43194c6127df1ce3d29242f719645de3c11fd7c0 | |
| ToppCell | Ciliated_cells-B-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 7.29e-04 | 164 | 48 | 3 | fd30c55d0d75ef8b9396435d836187168095152b | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.42e-04 | 165 | 48 | 3 | 4b4e75ad0eb0a6b00c30a000ec6267e23ba2e496 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.42e-04 | 165 | 48 | 3 | 82530f96aaefe28a13bad0474bbad043f127a86c | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.42e-04 | 165 | 48 | 3 | 0c714e852f912b5749de4cb0895406673979b2e6 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.55e-04 | 166 | 48 | 3 | 9e98e6070055bfc780becee52d77830e06b6d854 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.68e-04 | 167 | 48 | 3 | d78356bf0c473816dbabaee51984940bd822f84e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.82e-04 | 168 | 48 | 3 | fc80e4fecfc92458eb627013a983041d8ca025a9 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.95e-04 | 169 | 48 | 3 | 20fbf78382fb0ba9a63ab1aa0abc615476994ac5 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.95e-04 | 169 | 48 | 3 | 8bca402e144819cb9a8d431d6bf9429be2fff6d6 | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.09e-04 | 170 | 48 | 3 | d70aaa0f4e5034bb9f61b832b5f9123870936d3c | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.37e-04 | 172 | 48 | 3 | 63a91974b12c3f7f0c6bf66c30088d7fc07f5cea | |
| ToppCell | Ciliated_cells-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 8.37e-04 | 172 | 48 | 3 | 187ae91148d293537afc77e10da2b64302322224 | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.37e-04 | 172 | 48 | 3 | 7c238a7375341d4647ba7274d93fddfb6fae7ce4 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.51e-04 | 173 | 48 | 3 | c3762655caa79ac4879876f470d32578a3c93b01 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.51e-04 | 173 | 48 | 3 | 8ac2e9d39c0f76e674f8bd59d1da246bab4867c8 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.65e-04 | 174 | 48 | 3 | d0e3d15731de6c19c232e3aa492c39d8151cf4ed | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D122|Adult / Lineage, Cell type, age group and donor | 8.94e-04 | 176 | 48 | 3 | 3fee8a367bb9755aca1b7fcc968b08e51b6e9436 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.94e-04 | 176 | 48 | 3 | dee780cfa85234a7cd7bf440b66b84cec959893e | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.94e-04 | 176 | 48 | 3 | 87de432c680b80555342afac864599bbc002c040 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.09e-04 | 177 | 48 | 3 | aef050784abbba45c4ab4e8328339c8739c5c453 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.09e-04 | 177 | 48 | 3 | 4d2cdb57b427a42085c5f9affa0967b15e84dec3 | |
| ToppCell | IIH-CD8-antiviral_CD4|IIH / Condition, Cell_class and T cell subcluster | 9.09e-04 | 177 | 48 | 3 | fe73608c40701eca88b260aeb5c0640d7bee72ba | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.09e-04 | 177 | 48 | 3 | 3081ce5fc66a1bb833719d6c0e0a6fc7115eeb91 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.09e-04 | 177 | 48 | 3 | c9e8149639551a4c8daa90fcb2b895fdcff2e2ba | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.24e-04 | 178 | 48 | 3 | edc7143dc9959d36057cb9471681a23afcbc8cce | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_HNRNPA1P46|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.24e-04 | 178 | 48 | 3 | b863fc85d2449f25e6cea289459a7bb1f89583fd | |
| ToppCell | facs-Marrow-KLS-24m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.39e-04 | 179 | 48 | 3 | 5297f7459b40ca780a1983fecc1bb9c035c7677e | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-mature_enterocytic-Paneth|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.39e-04 | 179 | 48 | 3 | 6405010e8136a4d9bab356f628e36e3194911112 | |
| ToppCell | mild_COVID-19_(asymptomatic)-cDC|World / disease group, cell group and cell class (v2) | 9.54e-04 | 180 | 48 | 3 | 68d1c867734fb2977b01ac686b20bf602f9a6b72 | |
| Drug | Fluocinonide [356-12-7]; Down 200; 8uM; MCF7; HT_HG-U133A | 3.63e-06 | 198 | 48 | 6 | 3839_DN | |
| Drug | Methotrexate [59-05-2]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 3.90e-05 | 181 | 48 | 5 | 5419_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 500uM; HL60; HT_HG-U133A | 4.91e-05 | 190 | 48 | 5 | 6199_UP | |
| Drug | Piribedil hydrochloride [78213-63-5]; Down 200; 12uM; MCF7; HT_HG-U133A | 5.04e-05 | 191 | 48 | 5 | 5434_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A | 5.16e-05 | 192 | 48 | 5 | 1284_UP | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | 5.42e-05 | 194 | 48 | 5 | 1632_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A | 5.56e-05 | 195 | 48 | 5 | 2566_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HG-U133A | 5.56e-05 | 195 | 48 | 5 | 1732_UP | |
| Drug | Pyrimethamine [58-14-0]; Down 200; 16uM; MCF7; HT_HG-U133A | 5.70e-05 | 196 | 48 | 5 | 4779_DN | |
| Drug | Dobutamine hydrochloride [49745-95-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 5.70e-05 | 196 | 48 | 5 | 3206_DN | |
| Drug | Cyclizine hydrochloride [303-25-3]; Down 200; 13.2uM; PC3; HT_HG-U133A | 5.83e-05 | 197 | 48 | 5 | 5100_DN | |
| Drug | Josamycin [16846-24-5]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 5.83e-05 | 197 | 48 | 5 | 5692_DN | |
| Drug | Minoxidil [38304-91-5]; Up 200; 19.2uM; MCF7; HT_HG-U133A | 5.83e-05 | 197 | 48 | 5 | 4800_UP | |
| Drug | PHA-00846566E [724718-26-7]; Up 200; 10uM; MCF7; HT_HG-U133A | 6.12e-05 | 199 | 48 | 5 | 7081_UP | |
| Disease | matrix metalloproteinase measurement | 1.76e-04 | 13 | 45 | 2 | EFO_0004744 | |
| Disease | myeloid white cell count | 5.04e-04 | 937 | 45 | 7 | EFO_0007988 | |
| Disease | TEMPS-A questionnaire | 6.67e-04 | 25 | 45 | 2 | EFO_0004783 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KVEERRERYMDSYDI | 256 | Q969T7 | |
| RERYMDSYDIVLEKD | 261 | Q969T7 | |
| QEERERLVRMYFDKY | 526 | Q9NVI7 | |
| EKDMAVRDRGLFYYR | 506 | Q9Y6B7 | |
| EYEPEMGKVYRADRK | 121 | O14983 | |
| MRRDAYYFDPEIPKD | 56 | Q5T5A4 | |
| MEKDSYPRFLRSDLY | 1171 | P49796 | |
| KAYCVYRREMDPEID | 1876 | Q14571 | |
| DQSKYPIRESEMREY | 506 | Q9HCI5 | |
| PIRESEMREYIVKEY | 511 | Q9HCI5 | |
| RPRIVYDEKVDMFSY | 1436 | Q38SD2 | |
| SDKARYDREMKNYVP | 66 | P26583 | |
| NFPEEMATYLRYVRR | 281 | Q9HCP0 | |
| ENFPEEMATYLRYVR | 281 | P78368 | |
| DIPRYKRMVERYYAD | 2041 | O43157 | |
| RDYMNARRVAKEYET | 211 | Q12996 | |
| DFDIEMALRKYPVRY | 2831 | Q6ZR08 | |
| KREDYLYAVRDREMF | 76 | O95298 | |
| DMYRTREPRVFKEDY | 296 | Q8NEV8 | |
| MKRRRDFYAAYPLTE | 91 | P35227 | |
| VMDVKPVDYREYGRR | 591 | P27694 | |
| PFEEIRAKYYREMKR | 791 | Q8NCM8 | |
| RLYEREDYRGQMIEF | 91 | P07320 | |
| AMRYYYKREILERVD | 266 | Q9NZC4 | |
| SGAYRMKIYDRDELR | 86 | P07316 | |
| ADKVRYDREMKDYGP | 66 | O15347 | |
| MDYLSRLYEREIKDF | 411 | Q9NV70 | |
| KDPKFAEMEERFYRY | 601 | Q14839 | |
| AEMEERFYRYGIKPE | 606 | Q14839 | |
| RIEERYRPSMEGYRA | 236 | O60716 | |
| YLALRKMREYGVERD | 111 | Q9BQ95 | |
| SVRPLLDDEEYYRME | 191 | Q92523 | |
| ELRERPFYGRLVKYM | 71 | Q13232 | |
| FVNIYYETMDKRRRA | 21 | Q9NPJ8 | |
| TEEFYRYMLRDIERD | 1191 | Q2M3C7 | |
| RRYPKEVQDLYETMR | 241 | O75478 | |
| RYILEMYCEEPFVRE | 261 | Q9Y606 | |
| RLTDKEADEYYMRRR | 316 | Q6ZSJ9 | |
| YFRMKDEVFRGSRPY | 541 | O60733 | |
| REKGMYFRRELDRYS | 946 | Q9UPX8 | |
| RDVKRRKMAYEYADE | 36 | O60783 | |
| MSYRRELEKYRDLDE | 1 | P28289 | |
| TPFKDDRYYRLAPMR | 131 | Q9P2C4 | |
| PETDDYRYFDPKMLR | 561 | Q8WVM8 | |
| DERKRPYNSMYETRE | 546 | O95391 | |
| YETREPTEEEMEAYR | 556 | O95391 | |
| DRKDGSFIVRYRMYA | 91 | Q6UW63 | |
| KREDYLYAVRDREMF | 76 | E9PQ53 | |
| HRLRYEDRVPMYEEQ | 1076 | Q07157 | |
| RLDRDEERAYVLYMK | 51 | P40818 | |
| LLEEMRERKYDGYAR | 686 | Q12965 | |
| LNRFERPMDYYEDLK | 501 | Q9NQS3 |